AI-generated summary
The authors evaluated a large-spot subthreshold 810 nm infrared laser in a prospective fellow-eye controlled case series of patients with diabetic macular edema. The study was stopped early after one patient developed a choroidal infarct with profound vision loss, and among the remaining 10 patients, the authors report a trend toward better visual acuity and a significant reduction in central macular thickness compared with fellow eyes. The authors conclude the protocol is unpredictable and should not be used without further modification.
- Who or what was studied
- Patients with clinically significant diabetic macular edema; 11 patients enrolled, with analysis of 10 after early termination
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The study was small, terminated prematurely after a serious complication, and the visual acuity difference did not reach statistical significance (P = 0.08).
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.